KTH Royal Institute of Technology

A team of Swedish researchers has received $3.3 million to develop a new nanotechnology platform for detecting blood-borne markers in lung and breast cancer.

The study found eight potential protein biomarkers differentially expressed in elderly Alzheimer's disease patients, and researchers are planning an expanded study.

NEW YORK (GenomeWeb News) – A consortium of European research institutions and private partners will use €5.3 million ($7.4 million) in funding to develop a microfluidics-based lab-on-a-chip device to identify and measure the concentration of circulating tumor cells in blood, one of the partners,

Name: Peter Nilsson
Title: Platform Director, Affinity Proteomics, SciLifeLab, Stockholm

While many countries are cutting back on funding for life science research, Sweden is not one of them, as the Northern European country's Prime Minister Fredrik Reinfeldt this week confirmed that his government intends to invest $320 million in life sciences over the next four ye

As part of the deal, KTH will also serve as a reference site for Arrayjet, and the two organizations will work together on publications and technology development.

When most people think of the array market, they might think of the whole-genome genotyping chips sold by firms like Affymetrix and Illumina. But for providers of array slides, printers, and scanners, the market increasingly is in protein chips, and business is good.

BioSilta said that the use of EnBase Flo will increase the efficiency of the secondary screening process by allowing the KTH researchers to scale down from a shake-flask culture format to a 96-well microtiter plate format.

The university is using the company’s EnBase technology in its proteomics studies.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.